{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,24]],"date-time":"2026-08-24T17:37:59Z","timestamp":1787593079695,"version":"build-2736575974"},"reference-count":54,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T00:00:00Z","timestamp":1775001600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T00:00:00Z","timestamp":1775001600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,4,13]],"date-time":"2026-04-13T00:00:00Z","timestamp":1776038400000},"content-version":"vor","delay-in-days":12,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Indian Heart Journal"],"published-print":{"date-parts":[[2026,4]]},"DOI":"10.1016\/j.ihj.2026.04.006","type":"journal-article","created":{"date-parts":[[2026,4,17]],"date-time":"2026-04-17T15:39:17Z","timestamp":1776440357000},"update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":3,"title":["Frailty and advanced age in atrial fibrillation: Implications for treatment strategies and clinical outcomes \u2013 A systematic review"],"prefix":"10.1016","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-7606-5826","authenticated-orcid":false,"given":"Akash","family":"Batta","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4492-637X","authenticated-orcid":false,"given":"Razieh","family":"Parizad","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5433-0433","authenticated-orcid":false,"given":"Juniali","family":"Hatwal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ankur","family":"Mittal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5511-2099","authenticated-orcid":false,"given":"Manjeet Kumar","family":"Goyal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4337-3603","authenticated-orcid":false,"given":"Bishav","family":"Mohan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"4","key":"10.1016\/j.ihj.2026.04.006_bib1","doi-asserted-by":"crossref","first-page":"1044","DOI":"10.3390\/jcm14041044","article-title":"Outcomes in atrial fibrillation patients with different clinical phenotypes: insights from the French population","volume":"14","author":"Fawzy","year":"2025","journal-title":"J Clin Med"},{"issue":"2","key":"10.1016\/j.ihj.2026.04.006_bib2","doi-asserted-by":"crossref","DOI":"10.1093\/europace\/euaf027","article-title":"Global, regional, and national burden of atrial fibrillation and atrial flutter from 1990 to 2021: sex differences and global burden projections to 2046\u2014a systematic analysis of the global burden of disease study 2021","volume":"27","author":"Tan","year":"2025","journal-title":"Europace"},{"issue":"4","key":"10.1016\/j.ihj.2026.04.006_bib3","doi-asserted-by":"crossref","DOI":"10.1093\/europace\/euae070","article-title":"Longer and better lives for patients with atrial fibrillation: the 9th AFNET\/EHRA consensus conference","volume":"26","author":"Linz","year":"2024","journal-title":"Europace"},{"issue":"11","key":"10.1016\/j.ihj.2026.04.006_bib4","article-title":"Prevalence, management, and comorbidities of adults with atrial fibrillation in the United States, 2019 to 2023","volume":"3","author":"Oltman","year":"2024","journal-title":"JACC (J Am Coll Cardiol): Advances"},{"issue":"16","key":"10.1016\/j.ihj.2026.04.006_bib5","doi-asserted-by":"crossref","first-page":"1501","DOI":"10.1016\/j.jacc.2024.07.014","article-title":"Minimum national prevalence of diagnosed atrial fibrillation inferred from California acute care facilities","volume":"84","author":"Noubiap","year":"2024","journal-title":"J Am Coll Cardiol"},{"issue":"1","key":"10.1016\/j.ihj.2026.04.006_bib6","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1038\/s43587-020-00017-z","article-title":"The physical frailty syndrome as a transition from homeostatic symphony to cacophony","volume":"1","author":"Fried","year":"2021","journal-title":"Nat Aging"},{"key":"10.1016\/j.ihj.2026.04.006_bib7","doi-asserted-by":"crossref","DOI":"10.1016\/j.arr.2022.101652","article-title":"Frailty prevalence and impact on outcomes in patients with atrial fibrillation: a systematic review and meta-analysis of 1,187,000 patients","volume":"79","author":"Proietti","year":"2022","journal-title":"Ageing Res Rev"},{"issue":"5","key":"10.1016\/j.ihj.2026.04.006_bib8","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1093\/eurheartj\/ehaa612","volume":"42","author":"Hindricks","year":"2021","journal-title":"Eur Heart J"},{"issue":"8","key":"10.1016\/j.ihj.2026.04.006_bib9","doi-asserted-by":"crossref","first-page":"afac192","DOI":"10.1093\/ageing\/afac192","article-title":"Epidemiology and impact of frailty in patients with atrial fibrillation in Europe","volume":"51","author":"Proietti","year":"2022","journal-title":"Age Ageing"},{"key":"10.1016\/j.ihj.2026.04.006_bib10","doi-asserted-by":"crossref","DOI":"10.1016\/j.archger.2022.104661","article-title":"Frailty and outcomes in older adults with non-valvular atrial fibrillation from the ANAFIE registry","volume":"101","author":"Akishita","year":"2022","journal-title":"Arch Gerontol Geriatr"},{"key":"10.1016\/j.ihj.2026.04.006_bib11","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1016\/j.ejim.2018.04.018","article-title":"Frailty and atrial fibrillation: a systematic review","volume":"56","author":"Villani","year":"2018","journal-title":"Eur J Intern Med"},{"key":"10.1016\/j.ihj.2026.04.006_bib12","doi-asserted-by":"crossref","DOI":"10.1016\/j.arr.2021.101527","article-title":"Impact of frailty on all-cause mortality and major bleeding in patients with atrial fibrillation: a meta-analysis","volume":"73","author":"He","year":"2022","journal-title":"Ageing Res Rev"},{"key":"10.1016\/j.ihj.2026.04.006_bib13","doi-asserted-by":"crossref","DOI":"10.1136\/bmj-2023-076246","article-title":"Management of atrial fibrillation in older adults","volume":"386","author":"Parks","year":"2024","journal-title":"Br Med J"},{"issue":"4","key":"10.1016\/j.ihj.2026.04.006_bib14","first-page":"279","article-title":"Safety of switching from a vitamin K antagonist to a non\u2013vitamin K antagonist oral anticoagulant in frail older patients with atrial fibrillation: results of the FRAIL-AF randomized controlled trial","volume":"149","author":"Joosten","year":"2024","journal-title":"Circulation"},{"issue":"8","key":"10.1016\/j.ihj.2026.04.006_bib15","doi-asserted-by":"crossref","DOI":"10.1001\/jamanetworkopen.2022.28500","article-title":"Outcomes and safety of very-low-dose edoxaban in frail patients with atrial fibrillation in the ELDERCARE-AF randomized clinical trial","volume":"5","author":"Akashi","year":"2022","journal-title":"JAMA Netw Open"},{"issue":"7","key":"10.1016\/j.ihj.2026.04.006_bib16","doi-asserted-by":"crossref","first-page":"1065","DOI":"10.1093\/europace\/euac022","article-title":"Impact of oral anticoagulation on the association between frailty and clinical outcomes in people with atrial fibrillation: nationwide primary care records on treatment analysis","volume":"24","author":"Wilkinson","year":"2022","journal-title":"EP Europace"},{"key":"10.1016\/j.ihj.2026.04.006_bib17","article-title":"The PRISMA 2020 statement: an updated guideline for reporting systematic reviews","volume":"372","author":"Page","year":"2021","journal-title":"Br Med J"},{"key":"10.1016\/j.ihj.2026.04.006_bib18","article-title":"RoB 2: a revised tool for assessing risk of bias in randomised trials","volume":"366","author":"Sterne","year":"2019","journal-title":"Br Med J"},{"key":"10.1016\/j.ihj.2026.04.006_bib19","series-title":"The Newcastle-Ottawa Scale (NOS) for Assessing the Quality of Nonrandomised Studies in meta-analyses","author":"Wells","year":"2000"},{"issue":"3","key":"10.1016\/j.ihj.2026.04.006_bib20","doi-asserted-by":"crossref","first-page":"917","DOI":"10.1007\/s11845-020-02190-x","article-title":"Impact of atrial fibrillation on frailty and functionality in older adults","volume":"189","author":"Koca","year":"2020","journal-title":"Ir J Med Sci"},{"key":"10.1016\/j.ihj.2026.04.006_bib21","doi-asserted-by":"crossref","DOI":"10.1016\/j.archger.2020.104103","article-title":"The relationship between atrial fibrillation and frailty in community-dwelling older adults","volume":"90","author":"Yang","year":"2020","journal-title":"Arch Gerontol Geriatr"},{"issue":"3","key":"10.1016\/j.ihj.2026.04.006_bib22","doi-asserted-by":"crossref","DOI":"10.1016\/j.rpth.2023.100129","article-title":"Frailty and subsequent adverse outcomes in older patients with atrial fibrillation treated with oral anticoagulants: the Shizuoka study","volume":"7","author":"Nishimura","year":"2023","journal-title":"Research and Practice in Thrombosis and Haemostasis"},{"issue":"2","key":"10.1016\/j.ihj.2026.04.006_bib23","doi-asserted-by":"crossref","first-page":"196","DOI":"10.1093\/ageing\/afy180","article-title":"Management of atrial fibrillation for older people with frailty: a systematic review and meta-analysis","volume":"48","author":"Wilkinson","year":"2019","journal-title":"Age Ageing"},{"issue":"1","key":"10.1016\/j.ihj.2026.04.006_bib24","doi-asserted-by":"crossref","DOI":"10.1161\/JAHA.120.018557","article-title":"Association between frailty and atrial fibrillation in older adults: the framingham heart study offspring cohort","volume":"10","author":"Orkaby","year":"2021","journal-title":"J Am Heart Assoc"},{"issue":"6","key":"10.1016\/j.ihj.2026.04.006_bib25","doi-asserted-by":"crossref","first-page":"551","DOI":"10.1016\/j.hlc.2015.12.002","article-title":"The impact of frailty on mortality, length of stay and re-hospitalisation in older patients with atrial fibrillation","volume":"25","author":"Nguyen","year":"2016","journal-title":"Heart Lung Circ"},{"issue":"12","key":"10.1016\/j.ihj.2026.04.006_bib26","doi-asserted-by":"crossref","first-page":"2933","DOI":"10.1161\/STROKEAHA.118.020232","article-title":"Effectiveness and safety of oral anticoagulants among nonvalvular atrial fibrillation patients: the ARISTOPHANES study","volume":"49","author":"Lip","year":"2018","journal-title":"Stroke"},{"issue":"1","key":"10.1016\/j.ihj.2026.04.006_bib27","first-page":"59","article-title":"Influence of frailty on anticoagulant prescription and clinical outcomes after 1-year follow-up in hospitalised older patients with atrial fibrillation. Internal and emergency","volume":"14","author":"Gullon","year":"2019","journal-title":"Medicine"},{"issue":"9","key":"10.1016\/j.ihj.2026.04.006_bib28","doi-asserted-by":"crossref","first-page":"1317","DOI":"10.1016\/j.amjcard.2020.01.049","article-title":"Relation of frailty to outcomes after catheter ablation of atrial fibrillation","volume":"125","author":"Kundi","year":"2020","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.ihj.2026.04.006_bib29","doi-asserted-by":"crossref","first-page":"247","DOI":"10.2147\/CIA.S453527","article-title":"Effects of anticoagulant therapy and frailty in the elderly patients with atrial fibrillation","author":"Ding","year":"2024","journal-title":"Clin Interv Aging"},{"issue":"16","key":"10.1016\/j.ihj.2026.04.006_bib30","doi-asserted-by":"crossref","first-page":"1509","DOI":"10.1056\/NEJMoa1817083","article-title":"Antithrombotic therapy after acute coronary syndrome or PCI in atrial fibrillation","volume":"380","author":"Lopes","year":"2019","journal-title":"N Engl J Med"},{"issue":"1","key":"10.1016\/j.ihj.2026.04.006_bib31","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1186\/s12916-020-01870-w","article-title":"Clinical outcomes in patients with atrial fibrillation and frailty: insights from the ENGAGE AF-TIMI 48 trial","volume":"18","author":"Wilkinson","year":"2020","journal-title":"BMC Med"},{"issue":"10","key":"10.1016\/j.ihj.2026.04.006_bib32","doi-asserted-by":"crossref","first-page":"2509","DOI":"10.1111\/jce.70032","article-title":"Age, frailty, and outcomes after atrial fibrillation ablation: a nationwide cohort study","volume":"36","author":"Bolaji","year":"2025","journal-title":"J Cardiovascular Electrophysiol"},{"issue":"1","key":"10.1016\/j.ihj.2026.04.006_bib33","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1093\/ehjqcco\/qcad019","article-title":"Impact of frailty on the effectiveness and safety of non-vitamin K antagonist oral anticoagulants (NOACs) in patients with atrial fibrillation: a nationwide cohort study","volume":"10","author":"Grymonprez","year":"2024","journal-title":"European Heart Journal-Quality of Care and Clinical Outcomes"},{"issue":"4","key":"10.1016\/j.ihj.2026.04.006_bib34","first-page":"341","article-title":"Anticoagulant treatment in elderly patients with atrial fibrillation: a position paper","volume":"17","author":"Hanon","year":"2019","journal-title":"Geriatrie et psychologie neuropsychiatrie du vieillissement"},{"issue":"2","key":"10.1016\/j.ihj.2026.04.006_bib35","first-page":"105","article-title":"Atrial fibrillation and frailty","volume":"17","author":"Guo","year":"2020","journal-title":"Journal of geriatric cardiology: JGC"},{"key":"10.1016\/j.ihj.2026.04.006_bib36","doi-asserted-by":"crossref","DOI":"10.3389\/fphar.2024.1476464","article-title":"Potentially inappropriate prescribing in polymedicated older adults with atrial fibrillation and multimorbidity: a Swedish national register-based cohort study","volume":"15","author":"Amrouch","year":"2024","journal-title":"Front Pharmacol"},{"issue":"4","key":"10.1016\/j.ihj.2026.04.006_bib37","first-page":"393","article-title":"Association between atrial fibrillation symptoms, quality of life, and patient outcomes: results from the outcomes registry for better informed treatment of atrial Fibrillation (ORBIT-AF)","volume":"8","author":"Freeman","year":"2015","journal-title":"Circulation: Cardiovascular Quality and Outcomes"},{"issue":"18","key":"10.1016\/j.ihj.2026.04.006_bib38","doi-asserted-by":"crossref","first-page":"1735","DOI":"10.1056\/NEJMoa2012883","article-title":"Low-dose edoxaban in very elderly patients with atrial fibrillation","volume":"383","author":"Okumura","year":"2020","journal-title":"N Engl J Med"},{"issue":"8","key":"10.1016\/j.ihj.2026.04.006_bib39","doi-asserted-by":"crossref","first-page":"1662","DOI":"10.1111\/jgs.15956","article-title":"Comparisons between oral anticoagulants among older nonvalvular atrial fibrillation patients","volume":"67","author":"Deitelzweig","year":"2019","journal-title":"J Am Geriatr Soc"},{"issue":"12","key":"10.1016\/j.ihj.2026.04.006_bib40","doi-asserted-by":"crossref","first-page":"2051","DOI":"10.1016\/j.amjcard.2019.02.060","article-title":"Meta-analysis of direct-acting oral anticoagulants compared with warfarin in patients> 75 years of age","volume":"123","author":"Malik","year":"2019","journal-title":"Am J Cardiol"},{"issue":"3","key":"10.1016\/j.ihj.2026.04.006_bib41","doi-asserted-by":"crossref","DOI":"10.1001\/jamanetworkopen.2023.4086","article-title":"Comparative effectiveness and safety of oral anticoagulants by dementia status in older patients with atrial fibrillation","volume":"6","author":"Lin","year":"2023","journal-title":"JAMA Netw Open"},{"issue":"11","key":"10.1016\/j.ihj.2026.04.006_bib42","doi-asserted-by":"crossref","first-page":"1515","DOI":"10.7326\/M22-0511","article-title":"Comparative effectiveness and safety between apixaban, dabigatran, edoxaban, and rivaroxaban among patients with atrial fibrillation: a multinational population-based cohort study","volume":"175","author":"Lau","year":"2022","journal-title":"Ann Intern Med"},{"issue":"7","key":"10.1016\/j.ihj.2026.04.006_bib43","article-title":"Very elderly patients with atrial fibrillation treated with edoxaban: impact of frailty on outcomes","volume":"2","author":"Denas","year":"2023","journal-title":"JACC (J Am Coll Cardiol): Advances"},{"issue":"9","key":"10.1016\/j.ihj.2026.04.006_bib44","doi-asserted-by":"crossref","first-page":"1214","DOI":"10.7326\/M20-7141","article-title":"Frailty and clinical outcomes of direct oral anticoagulants versus warfarin in older adults with atrial fibrillation: a cohort study","volume":"174","author":"Kim","year":"2021","journal-title":"Ann Intern Med"},{"issue":"4","key":"10.1016\/j.ihj.2026.04.006_bib45","doi-asserted-by":"crossref","first-page":"668","DOI":"10.1002\/joa3.12364","article-title":"Application of the simple atrial fibrillation better care pathway for integrated care management in frail patients with atrial fibrillation: a nationwide cohort study","volume":"36","author":"Yang","year":"2020","journal-title":"Journal of arrhythmia"},{"issue":"2","key":"10.1016\/j.ihj.2026.04.006_bib46","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1016\/j.jacc.2021.10.037","article-title":"Management of atrial fibrillation in patients 75 years and older: JACC state-of-the-art review","volume":"79","author":"Volgman","year":"2022","journal-title":"J Am Coll Cardiol"},{"issue":"3","key":"10.1016\/j.ihj.2026.04.006_bib47","doi-asserted-by":"crossref","first-page":"625","DOI":"10.1007\/s10840-023-01662-1","article-title":"Frailty and associated outcomes in patients undergoing percutaneous left atrial appendage occlusion: findings from the NCDR LAAO registry","volume":"67","author":"Darden","year":"2024","journal-title":"J Intervent Card Electrophysiol"},{"issue":"1","key":"10.1016\/j.ihj.2026.04.006_bib48","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1007\/s10840-022-01266-1","article-title":"Association of advanced age with procedural complications and in-hospital outcomes from left atrial appendage occlusion device implantation in patients with atrial fibrillation: insights from the National inpatient sample of 36,065 procedures","volume":"65","author":"Munir","year":"2022","journal-title":"J Intervent Card Electrophysiol"},{"issue":"1","key":"10.1016\/j.ihj.2026.04.006_bib49","doi-asserted-by":"crossref","DOI":"10.1161\/JAHA.116.004699","article-title":"Efficacy and safety of apixaban compared with warfarin in patients with atrial fibrillation and peripheral artery disease: insights from the ARISTOTLE trial","volume":"6","author":"Hu","year":"2017","journal-title":"J Am Heart Assoc"},{"issue":"25","key":"10.1016\/j.ihj.2026.04.006_bib50","doi-asserted-by":"crossref","first-page":"3122","DOI":"10.1016\/j.jacc.2020.04.067","article-title":"Left atrial appendage closure versus direct oral anticoagulants in high-risk patients with atrial fibrillation","volume":"75","author":"Osmancik","year":"2020","journal-title":"J Am Coll Cardiol"},{"issue":"5","key":"10.1016\/j.ihj.2026.04.006_bib51","doi-asserted-by":"crossref","first-page":"229","DOI":"10.4330\/wjc.v15.i5.229","article-title":"Atrial fibrillation and coronary artery disease: an integrative review focusing on therapeutic implications of this relationship","volume":"15","author":"Batta","year":"2023","journal-title":"World J Cardiol"},{"issue":"6","key":"10.1016\/j.ihj.2026.04.006_bib52","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1016\/j.ihj.2022.11.009","article-title":"Predictors of dementia amongst newly diagnosed non-valvular atrial fibrillation patients","volume":"74","author":"Batta","year":"2022","journal-title":"Indian Heart J"},{"issue":"6","key":"10.1016\/j.ihj.2026.04.006_bib53","doi-asserted-by":"crossref","DOI":"10.4330\/wjc.v17.i6.106147","article-title":"Metabolic-dysfunction associated steatotic liver disease and atrial fibrillation: a review of pathogenesis","volume":"17","author":"Bharaj","year":"2025","journal-title":"World J Cardiol"},{"issue":"5\u20136","key":"10.1016\/j.ihj.2026.04.006_bib54","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1080\/14796678.2024.2354110","article-title":"Impact of initial high sensitivity C-reactive protein on outcomes in nonvalvular atrial fibrillation: an observational study","volume":"20","author":"Batta","year":"2024","journal-title":"Future Cardiol"}],"container-title":["Indian Heart Journal"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0019483226000593?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0019483226000593?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,4,21]],"date-time":"2026-04-21T11:40:13Z","timestamp":1776771613000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0019483226000593"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,4]]},"references-count":54,"alternative-id":["S0019483226000593"],"URL":"https:\/\/doi.org\/10.1016\/j.ihj.2026.04.006","relation":{},"ISSN":["0019-4832"],"issn-type":[{"value":"0019-4832","type":"print"}],"subject":[],"published":{"date-parts":[[2026,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Frailty and advanced age in atrial fibrillation: Implications for treatment strategies and clinical outcomes \u2013 A systematic review","name":"articletitle","label":"Article Title"},{"value":"Indian Heart Journal","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ihj.2026.04.006","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Cardiological Society of India. Published by Elsevier, a division of RELX India, Pvt. Ltd.","name":"copyright","label":"Copyright"}]}}